Literature DB >> 33441404

Specific Norovirus Interaction with Lewis x and Lewis a on Human Intestinal Inflammatory Mucosa during Refractory Inflammatory Bowel Disease.

Georges Tarris1, Alexis de Rougemont2,3, Marie Estienney2,3, Maeva Charkaoui4, Thomas Mouillot4, Bernard Bonnotte5,6, Christophe Michiels4, Laurent Martin7,6, Gaël Belliot8,3.   

Abstract

Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC), is related to immunological and microbial factors, with the possible implication of enteric viruses. We characterized the interaction between human noroviruses (HuNoVs) and blood group antigens in refractory CD and UC using HuNoV virus-like particles (VLPs) and histological tissues. Immunohistochemistry was conducted on inflammatory tissue samples from the small intestine, colon, and rectum in 15 CD and 9 UC patients. Analysis of the regenerative mucosa of the colon and rectum revealed strong expression of sialylated Lewis a (sLea) and Lewis x (sLex) antigens and HuNoV VLP binding in the absence of ABO antigen expression in both UC and CD. Competition experiments using sialidase, lectins, and monoclonal antibodies demonstrated that HuNoV attachment mostly involved Lea and, to a lesser extent, Lex moieties on regenerative mucosa in both UC and CD. Further studies will be required to understand the implications of specific HuNoV binding to regenerative mucosa in refractory IBD.IMPORTANCE Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are progressive diseases affecting millions of people each year. Flare-ups during IBD result in severe mucosal alterations of the small intestine (in CD) and in the colon and rectum (in CD and UC). Immunohistochemical analysis of CD and UC samples showed strong expression of known tumoral markers sialyl Lewis a (CA19.9) and sialyl Lewis x (CD15s) antigens on colonic and rectal regenerative mucosa, concurrent with strong human norovirus (HuNov) VLP GII.4 affinity. Sialidase treatment and competition experiments using histo-blood group antigen (HBGA)-specific monoclonal antibodies and lectins clearly demonstrated the implication of the Lewis a moiety and, to a lesser extent, the Lewis x moiety in HuNov recognition in regenerative mucosa of CD and UC tissues. Further studies are required to explore the possible implications of enteric viruses in the impairment of epithelial repair and dysregulation of inflammatory pathways during severe IBD.
Copyright © 2021 Tarris et al.

Entities:  

Keywords:  Crohn’s disease; HBGA; gut inflammation; inflammation; norovirus; ulcerative colitis

Year:  2021        PMID: 33441404      PMCID: PMC7845605          DOI: 10.1128/mSphere.01185-20

Source DB:  PubMed          Journal:  mSphere        ISSN: 2379-5042            Impact factor:   4.389


  49 in total

1.  Ki-67: a useful marker for the evaluation of dysplasia in ulcerative colitis.

Authors:  S N Andersen; T O Rognum; A Bakka; O P Clausen
Journal:  Mol Pathol       Date:  1998-12

Review 2.  Advances in laboratory methods for detection and typing of norovirus.

Authors:  Jan Vinjé
Journal:  J Clin Microbiol       Date:  2014-07-02       Impact factor: 5.948

3.  Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner.

Authors:  Pengwei Huang; Ming Xia; Ming Tan; Weiming Zhong; Chao Wei; Leyi Wang; Ardythe Morrow; Xi Jiang
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

4.  Norovirus triggered microbiota-driven mucosal inflammation in interleukin 10-deficient mice.

Authors:  Marijana Basic; Lydia M Keubler; Manuela Buettner; Marcel Achard; Gerhard Breves; Bernd Schröder; Anna Smoczek; Anne Jörns; Dirk Wedekind; Nils H Zschemisch; Claudia Günther; Detlef Neumann; Stefan Lienenklaus; Siegfried Weiss; Mathias W Hornef; Michael Mähler; André Bleich
Journal:  Inflamm Bowel Dis       Date:  2014-03       Impact factor: 5.325

5.  Distribution of GICA in normal gastrointestinal and endocervical mucosae and in mucinous ovarian cysts using antibody NS 19-9.

Authors:  J Bara; E H Zabaleta; R Mollicone; M Nap; P Burtin
Journal:  Am J Clin Pathol       Date:  1986-02       Impact factor: 2.493

6.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.

Authors:  R H Riddell; H Goldman; D F Ransohoff; H D Appelman; C M Fenoglio; R C Haggitt; C Ahren; P Correa; S R Hamilton; B C Morson
Journal:  Hum Pathol       Date:  1983-11       Impact factor: 3.466

Review 7.  Colorectal mucin histochemistry in health and disease: a critical review.

Authors:  J R Jass; A M Roberton
Journal:  Pathol Int       Date:  1994-07       Impact factor: 2.534

8.  Distribution of blood group antigens A, B, H, Lewisa, and Lewisb in human normal, fetal, and malignant colonic tissue.

Authors:  M Yuan; S H Itzkowitz; A Palekar; A M Shamsuddin; P C Phelps; B F Trump; Y S Kim
Journal:  Cancer Res       Date:  1985-09       Impact factor: 12.701

9.  A FUT2 gene common polymorphism determines resistance to rotavirus A of the P[8] genotype.

Authors:  Berthe-Marie Imbert-Marcille; Laure Barbé; Mathilde Dupé; Béatrice Le Moullac-Vaidye; Bernard Besse; Cécile Peltier; Nathalie Ruvoën-Clouet; Jacques Le Pendu
Journal:  J Infect Dis       Date:  2013-11-25       Impact factor: 5.226

10.  Human norovirus targets enteroendocrine epithelial cells in the small intestine.

Authors:  Ian N Moore; Stanislav V Sosnovtsev; Kim Y Green; Stuart S Kaufman; Bianca M Nagata; Natthawan Chaimongkol; Daniel Y Kim; Eric A Levenson; Christine M Tin; Allison Behrle Yardley; Jordan A Johnson; Ana Beatriz F Barletta; Khalid M Khan; Nada A Yazigi; Sukanya Subramanian; Sangeetha R Moturi; Thomas M Fishbein
Journal:  Nat Commun       Date:  2020-06-02       Impact factor: 14.919

View more
  4 in total

1.  Intestinal Norovirus Binding Patterns in Nonsecretor Individuals.

Authors:  Georges Tarris; Marie Estienney; Philippe Daval-Frérot; Anne-Cécile Lariotte; Damien Aubignat; Karine Sé; Christophe Michiels; Laurent Martin; Alexis de Rougemont; Gaël Belliot
Journal:  J Virol       Date:  2022-09-19       Impact factor: 6.549

Review 2.  Epidemiology, Clinical Features, and Unusual Complications of Norovirus Infection in Taiwan: What We Know after Rotavirus Vaccines.

Authors:  Meng-Che Lu; Sheng-Chieh Lin; Yi-Hsiang Hsu; Shih-Yen Chen
Journal:  Pathogens       Date:  2022-04-09

3.  Epidemiological Impact of GII.17 Human Noroviruses Associated With Attachment to Enterocytes.

Authors:  Marie Estienney; Georges Tarris; Nicole Abou-Hamad; Alain Rouleau; Wilfrid Boireau; Rémi Chassagnon; Siwar Ayouni; Philippe Daval-Frerot; Laurent Martin; Frédéric Bouyer; Jacques Le Pendu; Alexis de Rougemont; Gael Belliot
Journal:  Front Microbiol       Date:  2022-04-27       Impact factor: 6.064

Review 4.  Finding the sweet spot: glycosylation mediated regulation of intestinal inflammation.

Authors:  Jennifer C Brazil; Charles A Parkos
Journal:  Mucosal Immunol       Date:  2021-11-15       Impact factor: 8.701

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.